Page last updated: 2024-08-26

nicotine and ST Elevated Myocardial Infarction

nicotine has been researched along with ST Elevated Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abdelrazek, HM; El-Azab, MF; El-Mas, MM; Youssef, ME	1

Other Studies

1 other study(ies) available for nicotine and ST Elevated Myocardial Infarction

Article	Year
α7-nAChRs-mediated therapeutic angiogenesis accounts for the advantageous effect of low nicotine doses against myocardial infarction in rats. European journal of pharmacology, 2021, May-05, Volume: 898 Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiogenesis Inducing Agents; Animals; Disease Models, Animal; Heme Oxygenase (Decyclizing); Isoproterenol; Male; Microvascular Density; Myocytes, Cardiac; Neovascularization, Physiologic; Nicotine; Nicotinic Agonists; Nitric Oxide; Nitric Oxide Synthase Type II; Rats, Wistar; Signal Transduction; ST Elevation Myocardial Infarction; Vascular Endothelial Growth Factor A	2021

Article

Year

α7-nAChRs-mediated therapeutic angiogenesis accounts for the advantageous effect of low nicotine doses against myocardial infarction in rats.

European journal of pharmacology, 2021, May-05, Volume: 898

Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiogenesis Inducing Agents; Animals; Disease Models, Animal; Heme Oxygenase (Decyclizing); Isoproterenol; Male; Microvascular Density; Myocytes, Cardiac; Neovascularization, Physiologic; Nicotine; Nicotinic Agonists; Nitric Oxide; Nitric Oxide Synthase Type II; Rats, Wistar; Signal Transduction; ST Elevation Myocardial Infarction; Vascular Endothelial Growth Factor A

2021